Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

PCOS is a complex hormonal disorder with no clear cause or single diagnostic test, and current treatments focus on symptoms.

The infant with a urea cycle disorder improved with treatment and a liver transplant.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Two enzyme defects in biotin metabolism cause severe skin, hair, and metabolic issues.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.

The document concludes that PCOS in teenagers is hard to diagnose, influenced by various factors, and should be managed with lifestyle changes and medication.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Biotin supplements significantly improved a young girl's uncombable hair.

A holistic treatment approach, including yoga, diet, exercise, and mindfulness, can effectively manage PCOS symptoms.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that more research is needed to fully understand the causes of PCOS.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.